Log in or Sign up for Free to view tailored content for your specialty!
Asthma and Respiratory Disorders News
New Jersey caps out-of-pocket inhaler, epinephrine autoinjector costs
Gov. Phil Murphy of New Jersey has signed legislation that will cap monthly out-of-pocket prescription costs for epinephrine autoinjectors at $25 and asthma inhalers at $50 in all state-regulated and public employee health insurance plans.
The Environment and Autoimmunity, Part 1
This episode delves into the history of the hygiene hypothesis. What do we know about different exposures changing risk for asthma and allergies, and do these exposures have the same protection for autoimmunity?
Log in or Sign up for Free to view tailored content for your specialty!
Cipla recalls six batches of albuterol inhalers for container defect
Six batches of albuterol sulfate inhalation aerosol 90 mcg (200 metered inhalation) were voluntarily recalled by the manufacturer due to container defects that may prevent them from releasing the proper dose.
Biomarkers predict type 2-high, uncontrolled asthma
Blood eosinophil counts, serum IgE and fractional exhaled nitric oxide may be used to classify patients with T2-high or uncontrolled asthma, according to a study published in Annals of Allergy, Asthma & Immunology.
Tezepelumab reduces ED visits, hospitalizations in severe, uncontrolled asthma
Tezepelumab reduced health care utilization for asthma across all outcomes measured, as well as the severity of exacerbations that required hospitalizations, according to a study published in Annals of Allergy, Asthma & Immunology.
Persistent rhinitis associated with IgE sensitization, total IgE levels
Persistent rhinitis and the presence of both rhinitis and asthma were associated with IgE sensitization and total IgE levels, according to a study published in Clinical and Translational Allergy.
Triple therapy improves asthma outcomes compared with pairs of medications
The use of an inhaled corticosteroid, long-acting beta 2 agonist and long-acting muscarinic antagonist improved asthma outcomes compared with use of just two of those medications, according to a study published in Respiratory Medicine.
Advantages vary with single- and multiple-inhaler therapies for patients with asthma
WASHINGTON — The use of single-inhaler and multiple-inhaler therapies for asthma control as needed offers a variety of pros and cons, according to a presentation at the American Thoracic Society International Conference.
Patients, physicians overestimate asthma treatment adherence compared with mobile app
Adherence with asthma medication was lower when recorded by a mobile app compared with patient-reported and physician-reported results, according to a study published in Clinical and Translational Allergy.
FDA approves generic tiotropium bromide inhalation powder
The FDA has approved Lupin’s 18 µg capsules of tiotropium bromide inhalation powder, according to a manufacturer-issued press release.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read